Prevalence and Functional Impact of Urinary Incontinence in Women With Chronic Obstructive Pulmonary Disease Undergoing Rehabilitation: a Cross-sectional Study

by palligoelme@gmail.com | Aug 21, 2025 | Clinical Trials

​ Conditions: COPD (Chronic Obstructive Pulmonary Disease); Urinary Incontinence (UI); Pulmonary Rehabilitation Sponsors: Fondation Hôpital Saint-Joseph Not yet recruiting Conditions: COPD (Chronic Obstructive Pulmonary Disease); Urinary Incontinence (UI); Pulmonary...

Magnetic Resonance-Guided Laser Interstitial Thermal Therapy for Brain Metastases Trial

by palligoelme@gmail.com | Aug 20, 2025 | Clinical Trials

​ Conditions: Brain Metastasases Interventions: Device: Laser interstitial thermal therapy Sponsors: Beijing Tiantan Hospital; Sinovation (Beijing) Medical Technology Completed Conditions: Brain Metastasases Interventions: Device: Laser interstitial thermal therapy...

Interaction Between Inorganic Nitrate Supplementation and Metformin in Individuals With Prediabetes

by palligoelme@gmail.com | Aug 20, 2025 | Clinical Trials

​ Conditions: Males; Females; Sedentary; Metformin; Prediabetes Interventions: Dietary Supplement: Dietary Supplement: Inorganic Nitrate (Beetroot juice); Dietary Supplement: Dietary supplement: Placebo (Nitrate-depleted beetroot juice) Sponsors: University of...

Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients

by palligoelme@gmail.com | Aug 20, 2025 | Clinical Trials

​ Conditions: AML, Adult Interventions: Drug: Daunorubicin/Idarubicin; Drug: Cytarabine; Drug: Azacitidine; Drug: Venetoclax Sponsors: Institute of Hematology & Blood Diseases Hospital, China Not yet recruiting Conditions: AML, Adult Interventions: Drug:...

HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer

by palligoelme@gmail.com | Aug 20, 2025 | Clinical Trials

​ Conditions: Pancreatic Cancer Interventions: Drug: HRS-4642+AG +Adebrelimab Sponsors: Ruijin Hospital; Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting Conditions: Pancreatic Cancer Interventions: Drug: HRS-4642+AG +Adebrelimab Sponsors: Ruijin Hospital;...